Jesse Kigozi
Cost-Utility Analysis of Routine Anxiety and Depression Screening in Patients Consulting for Osteoarthritis: Results From a Clinical, Randomized Controlled Trial
Kigozi, Jesse; Jowett, Sue; Nicholl, Barbara I.; Lewis, Martyn; Bartlam, Bernadette; Green, Daniel; Belcher, John; Clarkson, Kris; Lingard, Zoe; Pope, Christopher; Chew-Graham, Carolyn A.; Croft, Peter; Hay, Elaine; Peat, George; Mallen, Christian D.
Authors
Sue Jowett
Barbara I. Nicholl
Alyn Lewis a.m.lewis@keele.ac.uk
Bernadette Bartlam
Daniel Green
John Belcher j.belcher@keele.ac.uk
Kris Clarkson
Zoe Lingard
Christopher Pope
Carolyn Chew-Graham c.a.chew-graham@keele.ac.uk
Peter Croft
Elaine Hay e.m.hay@keele.ac.uk
George Peat
Christian Mallen c.d.mallen@keele.ac.uk
Abstract
OBJECTIVE: To investigate the cost-effectiveness (cost-utility) of introducing general practitioner screening for anxiety and depression in patients consulting with osteoarthritis (OA). METHODS: A cluster-randomised trial-based economic evaluation to assess general practitioners screening for anxiety and depression symptoms in patients consulting with OA compared to usual care (screening for pain intensity) was undertaken over a 12-month period from a UK National Health Service and Societal perspective. Patient-level mean costs and mean quality-adjusted life years (QALYs) were estimated and cost-effectiveness acceptability curves controlling for cluster-level data were constructed. The base-case analysis used the net-benefit regressions approach. The two-stage non-parametric sampling technique was explored in a sensitivity analysis. RESULTS: The base-case analysis demonstrated that the intervention was as costly as, and less effective than, the control (QALY diff, 95% CI: - 0.029 (95% CI -0.062 to 0.003)). In the base-case analyses, GP screening for anxiety and depression was unlikely to be a cost-effective option (probability < 5% at £20,000/QALY). Similar results were observed in all sensitivity analyses. CONCLUSIONS: Prompting GP's to routinely screen and manage comorbid anxiety and depression in patients presenting with OA is unlikely to be cost-effective. Further research is needed to explore clinically-effective and cost-effective models of managing anxiety and depression in patients presenting with clinical OA. This article is protected by copyright. All rights reserved.
Citation
Kigozi, J., Jowett, S., Nicholl, B. I., Lewis, M., Bartlam, B., Green, D., …Mallen, C. D. (2018). Cost-Utility Analysis of Routine Anxiety and Depression Screening in Patients Consulting for Osteoarthritis: Results From a Clinical, Randomized Controlled Trial. Arthritis Care and Research, 70(12), 1787-1794. https://doi.org/10.1002/acr.23568
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 27, 2018 |
Online Publication Date | Apr 2, 2018 |
Publication Date | Dec 1, 2018 |
Publicly Available Date | May 26, 2023 |
Journal | Arthritis Care and Research |
Print ISSN | 2151-464X |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 70 |
Issue | 12 |
Pages | 1787-1794 |
DOI | https://doi.org/10.1002/acr.23568 |
Keywords | case-finding, anxiety, cost-effectiveness, cost-utility, depression, economic evaluation, osteoarthritis, screening |
Publisher URL | http://doi.org/10.1002/acr.23568 |
Files
acr.23568.pdf
(197 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Reply
(2021)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search